These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 32799566)
1. Emerging therapeutics for the management of COVID 19. Debnath SK; Srivastava R; Omri A Expert Opin Emerg Drugs; 2020 Sep; 25(3):337-351. PubMed ID: 32799566 [TBL] [Abstract][Full Text] [Related]
2. Fighting COVID-19: A quick review of diagnoses, therapies, and vaccines. Shih HI; Wu CJ; Tu YF; Chi CY Biomed J; 2020 Aug; 43(4):341-354. PubMed ID: 32532623 [TBL] [Abstract][Full Text] [Related]
3. Emergence, Transmission, and Potential Therapeutic Targets for the COVID-19 Pandemic Associated with the SARS-CoV-2. Patil AM; Göthert JR; Khairnar V Cell Physiol Biochem; 2020 Aug; 54(4):767-790. PubMed ID: 32830930 [TBL] [Abstract][Full Text] [Related]
4. A Review of SARS-CoV-2 and the Ongoing Clinical Trials. Tu YF; Chien CS; Yarmishyn AA; Lin YY; Luo YH; Lin YT; Lai WY; Yang DM; Chou SJ; Yang YP; Wang ML; Chiou SH Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32290293 [TBL] [Abstract][Full Text] [Related]
5. COVID-19: Main therapeutic options. Hachfi W; Ben Lasfar N Tunis Med; 2020 Apr; 98(4):299-303. PubMed ID: 32395792 [No Abstract] [Full Text] [Related]
6. An overview of COVID-19. Shi Y; Wang G; Cai XP; Deng JW; Zheng L; Zhu HH; Zheng M; Yang B; Chen Z J Zhejiang Univ Sci B; 2020 May; 21(5):343-360. PubMed ID: 32425000 [TBL] [Abstract][Full Text] [Related]
7. Compounds with Therapeutic Potential against Novel Respiratory 2019 Coronavirus. Martinez MA Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32152082 [TBL] [Abstract][Full Text] [Related]
8. Antiviral Efficacies of FDA-Approved Drugs against SARS-CoV-2 Infection in Ferrets. Park SJ; Yu KM; Kim YI; Kim SM; Kim EH; Kim SG; Kim EJ; Casel MAB; Rollon R; Jang SG; Lee MH; Chang JH; Song MS; Jeong HW; Choi Y; Chen W; Shin WJ; Jung JU; Choi YK mBio; 2020 May; 11(3):. PubMed ID: 32444382 [TBL] [Abstract][Full Text] [Related]
9. Progress in Studies on Structural and Remedial Aspects of Newly Born Coronavirus, SARS-CoV-2. Gupta SP Curr Top Med Chem; 2020; 20(26):2362-2378. PubMed ID: 32962613 [TBL] [Abstract][Full Text] [Related]
10. Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate special control measures. Wang Y; Wang Y; Chen Y; Qin Q J Med Virol; 2020 Jun; 92(6):568-576. PubMed ID: 32134116 [TBL] [Abstract][Full Text] [Related]
11. Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial. Cuadrado-Lavín A; Olmos JM; Cifrian JM; Gimenez T; Gandarillas MA; García-Saiz M; Rebollo MH; Martínez-Taboada V; López-Hoyos M; Fariñas MC; Crespo J Trials; 2020 Jun; 21(1):472. PubMed ID: 32493494 [TBL] [Abstract][Full Text] [Related]
12. COVID-19: Underpinning Research for Detection, Therapeutics, and Vaccines Development. Aljabali AAA; Bakshi HA; Satija S; Metha M; Prasher P; Ennab RM; Chellappan DK; Gupta G; Negi P; Goyal R; Sharma A; Mishra V; Dureja H; Dua K; Tambuwala MM Pharm Nanotechnol; 2020; 8(4):323-353. PubMed ID: 32811406 [TBL] [Abstract][Full Text] [Related]
13. Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review. Wiersinga WJ; Rhodes A; Cheng AC; Peacock SJ; Prescott HC JAMA; 2020 Aug; 324(8):782-793. PubMed ID: 32648899 [TBL] [Abstract][Full Text] [Related]
14. Potential strategies for combating COVID-19. Shamim S; Khan M; Kharaba ZJ; Ijaz M; Murtaza G Arch Virol; 2020 Nov; 165(11):2419-2438. PubMed ID: 32778950 [TBL] [Abstract][Full Text] [Related]
15. Update on therapeutic approaches and emerging therapies for SARS-CoV-2 virus. Omolo CA; Soni N; Fasiku VO; Mackraj I; Govender T Eur J Pharmacol; 2020 Sep; 883():173348. PubMed ID: 32634438 [TBL] [Abstract][Full Text] [Related]
16. Medication therapy strategies for the coronavirus disease 2019 (COVID-19): recent progress and challenges. Yang X; Liu Y; Liu Y; Yang Q; Wu X; Huang X; Liu H; Cai W; Ma G Expert Rev Clin Pharmacol; 2020 Sep; 13(9):957-975. PubMed ID: 32746653 [TBL] [Abstract][Full Text] [Related]